Concepedia

Georg Wensing

GW

Statistics

Publications

38

Citations

3.1K

H-Index

24

Active since

1990

Affiliations

Bayer (Germany)(Current)

Friedrich-Alexander-Universität Erlangen-Nürnberg

Vanderbilt University

Universitätsklinikum Gießen und Marburg

University Hospital Bonn

Georg Wensing is an author at Bayer (Germany) specializing in medicine, pharmacology, and clinical pharmacology.

Publications per year

1990–2021

38

Publications

38

Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor

Dagmar Kubitza, Michael Becka, Barbara Voith et al. · Clinical Pharmacology & Therapeutics · 2005 · 652 citations

, , +16

Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939—an oral, direct Factor Xa inhibitor—after multiple dosing in healthy male subjects

Dagmar Kubitza, Michael Becka, Georg Wensing et al. · European Journal of Clinical Pharmacology · 2005 · 648 citations

, , +5

First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension

Friedrich Grimminger, Gerrit Weimann, R Frey et al. · European Respiratory Journal · 2009 · 249 citations · Full text

, , +17

Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study

T. Klotz, Richard Sachse, Albert Heidrich et al. · World Journal of Urology · 2001 · 163 citations

, , +10

Cinaciguat (BAY 58–2667) Improves Cardiopulmonary Hemodynamics in Patients With Acute Decompensated Heart Failure

Harald Lapp, Veselin Mitrović, Norbert Franz et al. · Circulation · 2009 · 149 citations · Full text

, , +17

1–5 of 38